Bio-Techne Corporation
NASDAQ: TECH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kim Kelderman
- Employees
- 3,100
- Headquarters
- Minneapolis, United States
- IPO year
- 1989
- Market cap
- $9.1B
- Website
- https://www.bio-techne.com
Loading TECH…
Loading profile data…Frequently asked questions about TECH
What does Bio-Techne Corporation (TECH) do?
Bio-Techne Corporation, headquartered in Minneapolis, Minnesota, is a global enterprise specializing in the development, production, and distribution of specialized life science tools, instrumentation, and support solutions for both research and clinical diagnostic markets. The company is organized into two key business units: Protein Sciences,...
Where does TECH trade?
Bio-Techne Corporation (TECH) trades on the NASDAQ Global Select.
What sector is TECH in?
Bio-Techne Corporation (TECH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Bio-Techne Corporation?
Kim Kelderman is the chief executive officer of Bio-Techne Corporation (TECH).
Where is Bio-Techne Corporation headquartered?
Bio-Techne Corporation is headquartered in United States.
Does TECH pay a dividend?
Yes — Bio-Techne Corporation (TECH) paid a trailing twelve-month dividend of USD 0.32 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TECH go public?
Bio-Techne Corporation (TECH) completed its initial public offering in 1989.